Skip to main content
Explore URMC


URMC / Pulmonary and Critical Care Medicine / Research / Respiratory Viruses

Respiratory Viruses

Influenza and Respiratory Syncytial Virus (RSV) infections are the two most common respiratory viral pathogens causing increased morbidity and mortality. For over 30 years, the University of Rochester has been one of the leading institutions studying human respiratory viral infections with Caroline B Hall, John Treanor, Edward E Walsh, and Ann R Falsey. Earlier work by CB Hall, and recent work by EE Walsh, and AR Falsey established RSV infections as a major cause of morbidity and mortality in young infants and elderly patients.  Despite universal infection by age 3, repeat RSV infections during adulthood are quite common suggesting immunity is partial at best.  Moreover, the host viral immune response is important in clearance of these viruses; however, it may also contribute to the pathology of severe lung disease.   Currently there is no vaccine for RSV; there are only vaccines to influenza.

F. Eun-Hyung Lee in the Pulmonary Critical Care Division has been performing translational studies by studying the human T and B cell responses during acute RSV and influenza infections in infants and elderly patients.  With cutting edge immune techniques, she has been studying T cell cytokine and B cell antibody mediated responses with correlates of clinical disease during acute viral infections and immune correlates of influenza and RSV-specific long-term memory responses that protect from future infections.  Her research focus is in the development of immunomodulators to decrease disease severity by understanding the T and B cell immune responses during natural infection.   She is also interested in vaccine immune responses that mediate long-term protection.